Alembic Pharma shares surge 5% on USFDA product approvals on January 2, 2024 at 6:03 am

Alembic Pharma is planning to launch over 20 products in the current financial year (FY24), with a focus on oral solids, injectables, and derma segments.

Leave a comment

Your email address will not be published. Required fields are marked *